Aurora Cannabis Inc. produces and distributes medical cannabis products in Canada and internationally. It is vertically integrated and horizontally diversified across every principal segment of the value chain, including facility engineering and design, cannabis breeding and genetics research, cannabis and hemp production, derivatives, value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil. It has a strategic agreement with Capcium Inc.; and partnership agreement with Evio Beauty Group Ltd., as well as collaborative agreement with McGill University. Aurora Cannabis Inc. is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Stock Exchange TSE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolTSE:ACB
CUSIPN/A
Phone+1-604-3625207
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins61.49%
Return on Equity7.80%
Return on Assets5.34%
Miscellaneous
EmployeesN/A
Outstanding Shares945,628,000
Market CapC$5.37 billion
Aurora Cannabis (TSE:ACB) Frequently Asked Questions
What is Aurora Cannabis' stock symbol?
Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."
How were Aurora Cannabis' earnings last quarter?
Aurora Cannabis Inc (TSE:ACB) announced its quarterly earnings data on Monday, May, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The company had revenue of $5.18 million for the quarter, compared to analysts' expectations of $7.44 million. Aurora Cannabis had a return on equity of 7.80% and a net margin of 61.49%. View Aurora Cannabis' Earnings History.
When is Aurora Cannabis' next earnings date?
What price target have analysts set for ACB?
2 Wall Street analysts have issued 12 month price objectives for Aurora Cannabis' shares. Their predictions range from C$9.00 to C$11.00. On average, they anticipate Aurora Cannabis' share price to reach C$10.00 in the next twelve months. This suggests that the stock has a possible downside of 9.3%. View Analyst Price Targets for Aurora Cannabis.
What is the consensus analysts' recommendation for Aurora Cannabis?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aurora Cannabis.
Who are some of Aurora Cannabis' key competitors?
Some companies that are related to Aurora Cannabis include MERCK KGAA/S (MKKGY), Merck KGaA (MRK), Valeant Pharmaceuticals Intl (VRX), Canopy Growth (WEED), STADA Arzneimittel (SAZ), Hikma Pharmaceuticals (HKMPY), Hikma Pharmaceuticals (HIK), Aphria (APH), MedReleaf (LEAF), Knight Therapeutics (KHTRF), Hydropothecary (THCX), OrganiGram (OGI), Supreme Cannabis (FIRE), Weed (BUDZ) and OrganiGram (OGRMF).
Who are Aurora Cannabis' key executives?
Aurora Cannabis' management team includes the folowing people:
- Mr. Terry Booth, Founder, CEO & Director (Age 53)
- Mr. Stephen Dobler, Founder, Pres & Director (Age 53)
- Mr. Glen Ibbott, Chief Financial Officer
- Mr. Allan John Cleiren, Chief Operating Officer
- Mr. Neil Belot, Chief Global Bus. Devel. Officer
Has Aurora Cannabis been receiving favorable news coverage?
Media coverage about ACB stock has been trending somewhat positive on Wednesday, Accern Sentiment reports. The research firm identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Aurora Cannabis earned a daily sentiment score of 0.18 on Accern's scale. They also assigned news coverage about the company an impact score of 46.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Aurora Cannabis.
How do I buy shares of Aurora Cannabis?
Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Aurora Cannabis' stock price today?
One share of ACB stock can currently be purchased for approximately C$11.02.
How big of a company is Aurora Cannabis?
Aurora Cannabis has a market capitalization of C$5.37 billion.
How can I contact Aurora Cannabis?
Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.
MarketBeat Community Rating for Aurora Cannabis (TSE ACB)
MarketBeat's community ratings are surveys of what our community members think about Aurora Cannabis and other stocks. Vote "Outperform" if you believe ACB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACB will underperform the S&P 500 over the long term. You may vote once every thirty days.
